Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 69,749	$ 23,634
Marketable investments	10,886	26,344
Accounts receivables, net	32,725	24,469
Inventory	9,651	9,976
Prepaid expenses	5,222	8,807
Other current assets	4,878	3,143
Total current assets	133,111	96,373
Property and equipment, net	53,237	51,971
Operating lease right-of-use assets	53,408	86,464
Intangibles, net	122,283	136,902
Goodwill	80,269	80,269
Equity investments	12,008	17,176
Other assets, net	2,376	3,685
Total assets	456,692	472,840
Current liabilities:
Accounts payable	18,554	47,515
Accrued payroll and related benefits	6,964	7,884
Accrued expenses and other current liabilities	91,924	58,456
Accrued legal settlements		174,752
Current portion of deferred revenue	256	652
Current portion of operating lease liabilities	13,051	13,880
Current portion of contingent consideration	397	397
Acquisition consideration	515	7,800
Income tax payable	12,926	300
Current portion of debt	120,362	16,286
Total current liabilities	264,949	327,922
Long-term debt, net of discount	21,741	19,130
Deferred tax liabilities, net	238	591
Deferred revenue	896	7,098
Derivative liabilities	1,600	300
Operating lease liabilities	52,446	85,208
Contingent consideration	550	48,949
Other long-term liabilities	3,305	5,311
Total liabilities not subject to compromise	345,725	494,509
Liabilities subject to compromise	308,923
Total liabilities	654,648	494,509
Commitments and contingencies (See Note 10)
Sorrento Therapeutics, Inc. equity (deficit)
Common stock, $0.0001 par value 750,000,000 shares authorized and 551,281,154 and 522,817,137 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	55	52
Additional paid-in capital	2,036,331	1,988,753
Accumulated other comprehensive income	2,240	1,501
Accumulated deficit	(2,194,275)	(1,959,447)
Treasury stock, 7,568,182 shares at cost at June 30, 2023, and December 31, 2022	(49,464)	(49,464)
Total Sorrento Therapeutics, Inc. stockholders deficit	(205,113)	(18,605)
Noncontrolling interests	7,157	(3,064)
Total deficit	(197,956)	(21,669)
Total liabilities and stockholders' equity (deficit)	$ 456,692	$ 472,840